Home > Acceleron Pharma Salary

Acceleron Pharma Salary

  • 42
  • 100
  • 86
Acceleron Pharma average salary is $37,375, median salary is $36,750 with a salary range from $36,000 to $40,000.
Acceleron Pharma salaries are collected from government agencies and companies. Each salary is associated with a real job position. Acceleron Pharma salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 3 Acceleron Pharma Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Public School Teacher 36,000-36,000 CAMBRIDGE, MA, 02139 2014 Acceleron Pharma Public School Teacher Salaries (4)
Acceleron Pharma CAMBRIDGE, MA Salaries
Public School Teacher 37,500-37,500 CAMBRIDGE, MA, 02139 2013 Acceleron Pharma Public School Teacher Salaries (4)
Acceleron Pharma CAMBRIDGE, MA Salaries
Public School Teacher 36,000-40,000 CAMBRIDGE, MA, 02139 2012 Acceleron Pharma Public School Teacher Salaries (4)
Acceleron Pharma CAMBRIDGE, MA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Acceleron Pharma salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Acceleron Pharma Jobs
See more Acceleron Pharma Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Acceleron Pharma... Information
  • Acceleron Pharma Inc
  • Industry: BioTech/Drugs
  • City: Cambridge, MA
  • Acceleron is a biopharmaceutical company developing drugs for important unmet medical needs through proprietary approaches that exploit the therapeutic potential of a large family of growth and differentiation factors. Drug candidates will include both novel agonists and antagonists. The company was founded in 2003 and builds upon important ongoing research in the laboratories of its academic founders and consultants.